Jacob Van Naarden

Insider Reports History

Entity
Individual
Location
C/O Eli Lilly & Co, Lilly Corporate Center, Indianapolis, IN
Signature
/s/ Jonathan Groff for Jacob Van Naarden, pursuant to authorization on file
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jacob Van Naarden:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ELI LILLY & Co EVP & Pres., Lilly Oncology Common Stock 19.6K $17M $868.88 Feb 10, 2025 Direct
ELI LILLY & Co EVP & Pres., Lilly Oncology Common Stock 4.34K $3.77M $868.88 Feb 10, 2025 Van Naarden Family Trust
ELI LILLY & Co EVP & Pres., Lilly Oncology Common Stock 4.3K $3.74M $868.88 Feb 10, 2025 By spouse
ELI LILLY & Co EVP & Pres., Lilly Oncology Restricted Stock Unit 4.11K $3.57M $868.88 Feb 10, 2025 Direct
ELI LILLY & Co EVP & Pres., Lilly Oncology Restricted Stock Unit 3.02K $2.23M $737.26 Feb 12, 2024 Direct

Insider Reports Filed by Jacob Van Naarden

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LLY ELI LILLY & Co Feb 10, 2025 2 $5.3M 4 Feb 12, 2025 EVP & Pres., Lilly Oncology
LLY ELI LILLY & Co Feb 1, 2025 3 -$1.14M 4 Feb 4, 2025 EVP & Pres., Lilly Oncology
LLY ELI LILLY & Co Oct 31, 2024 1 $0 4 Nov 1, 2024 EVP & Pres., Lilly Oncology
LLY ELI LILLY & Co Feb 12, 2024 2 $1.75M 4 Feb 14, 2024 EVP & Pres., Loxo@Lilly
LLY ELI LILLY & Co Feb 1, 2024 3 -$1.09M 4 Feb 2, 2024 EVP & Pres., Loxo@Lilly
LLY ELI LILLY & Co Feb 16, 2023 3 -$440K 4 Feb 21, 2023 EVP and CEO Loxo@Lilly
LLY ELI LILLY & Co Feb 10, 2023 1 $831K 4 Feb 14, 2023 EVP and CEO Loxo@Lilly
LLY ELI LILLY & Co Feb 16, 2022 3 -$533K 4 Feb 17, 2022 SVP, CEO LoxoONC, Pres LlyONC
LLY ELI LILLY & Co Dec 28, 2021 1 $0 4 Dec 30, 2021 SVP, CEO LoxoONC, Pres LlyONC
LLY ELI LILLY & Co Sep 5, 2021 0 $0 3 Sep 7, 2021 SVP, CEO LoxoONC, Pres LlyONC